Loading icon
More Enzyme, Less Branching, and More MS Risk
More Enzyme, Less Branching, and More MS Risk

This post covers Mkhikian and colleagues' 2011 Nature Communications study, which inverted the usual order of genetic work by screening biologically first and testing association last. It follows the N-glycan branching pathway and the L-PHA readout with the 15 to 20% threshold that sets the scale, the cytokine result where more Mgat1 produces less branching and the 250-fold affinity difference that explains it, the screen of MGAT1 exon 2 in 42 patients and the allelic expression data behind the haplotype, the enzyme kinetics that make the direction of effect conditional on substrate supply, the swainsonine blocking experiment that places vitamin D protection inside the branching pathway, and the association statistics run last, including interactions that hold despite CTLA-4 Thr17Ala having no point association at all.

Read more